SignalEU/UK
SOPHiA GENETICS SA (SOPH) Presents at 2026 UBS Global Healthcare Conference Transcript
High-priority alert based on source significance and keyword relevance.
Context
What happened: SOPHiA GENETICS co-founder Jurgi Camblong, now Executive Chairman, discussed the company's strategy, commercial adoption and business model at the 2026 UBS Global Healthcare Conference, in a session with UBS analyst Douglas Schenkel.
Why it matters: Camblong described the founding view that in precision medicine the value would lie in the data itself rather than just data production, and the session covered the company's work with hospitals, labs and biopharma companies.
What changed
SOPHiA GENETICS co-founder Jurgi Camblong, now Executive Chairman, discussed the company's strategy, commercial adoption and business model at the 2026 UBS Global Healthcare Conference, in a session with UBS analyst Douglas Schenkel.
Why it matters
Camblong described the founding view that in precision medicine the value would lie in the data itself rather than just data production, and the session covered the company's work with hospitals, labs and biopharma companies.